Reviews Open access

Intra-articular therapy with tumor necrosis factor-α antagonists: an update

Authors

Published
14 March 2014
Section
Reviews
Pages
257-263

Abstract

The aim of the study was to review from the present literature the intra-articular (IA) use of the TNF-blocking drugs. A total of 28 papers about this topic were found through a search in PubMed; the first publication’s date was July 2003. These studies include a total of 214 patients affected by 12 different joint diseases that reported a total of 1046 intra-articular therapies carried out in 10 different joint sites. Infliximab and etanercept were the most widely used medications. The safety of this treatment clearly emerges from our analysis, while more difficult was the evaluation of its efficacy. Nevertheless we deduced an ideal patient profile that may better respond to the IA anti-TNF treatment.

Supporting Agencies

none

Author Biography

  • S. Bello, Rheumatology Unit, Policlinico Hospital, University of Bari

    Già borsista,attualmente collaboratore esterno con finalità di ricerca,presso ambulatorio dedicato alle terapie biologiche,

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.